CASI Pharmaceuticals, Inc 20-F for FY2025
CASI Pharmaceuticals, Inc. (CASIF)
20-F
2026-05-15
For: 2025-12-31
View Original
Added on
May 16, 2026
About this 20-F
CASI Pharmaceuticals, Inc filed this 20-F on May 15, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $20.71M
- down 27.4% from $28.54M a year earlier
- Net loss
- $48.06M
- compared with a net loss of $39.26M a year earlier
- Diluted EPS
- -$2.59
- compared with -$2.56 a year earlier